Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir in Decompensated HBV Cirrhosis
NCT07816094Phase 4Recruiting
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in hepatitis B (HBV), sponsored by Bangabandhu Sheikh Mujib Medical University. Started Jan 2026; status: recruiting.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT07816094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816094.